HIV Research & Clinical Practice, Volume 9, Issue 3 (2008)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

HIV Clinical Trials, Volume 9, Issue 3 (2008)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Volume 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Original Articles

Article
Atazanavir in Patients with Persistent Viral Replication Despite HAART: Results from the French Prospective NADIS Cohort
L. Cuzin, P. Flandre, P. Pugliese, C. Duvivier, Y. Yazdanpanah, E. Billaud, I. Poizot-Martin, C. Katlama & the NADIS Group
Pages: 147-151
Published online: 06 Jan 2015
AbstractforAtazanavir in Patients with Persistent Viral Replication Despite HAART: Results from the French Prospective NADIS Cohort | References | PDF (110.7 KB)
  • 40 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Once-Daily Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir for the Treatment of HIV-1 Infection in Antiretroviral-Naïve Patients: A 48-Week Pilot Study
Richard Elion, Edwin deJesus, Michael Sension, Daniel Berger, William Towner, Gary Richmond, Marty St. Clair, Linda Yau, Belinda Ha & the COL102060 Study Team
Pages: 152-163
Published online: 06 Jan 2015
AbstractforOnce-Daily Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir for the Treatment of HIV-1 Infection in Antiretroviral-Naïve Patients: A 48-Week Pilot Study | References | PDF (348.3 KB)
  • 83 Views
  • 27 CrossRef citations
  • 0Altmetric
Free Access
Article
Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression
Brian A. Boyle, Dushyantha Jayaweera, Mallory D. Witt, Kristy Grimm, Jen-fue Maa & Daniel W. Seekins
Pages: 164-176
Published online: 06 Jan 2015
AbstractforRandomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression | References | PDF (433.8 KB)
  • 118 Views
  • 42 CrossRef citations
  • 0Altmetric
Free Access
Article
Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials
Alan R. Lifson, Waldo H. Belloso, Cate Carey, Richard T. Davey, Daniel Duprez, Wafaa M. El-Sadr, Jose M. Gatell, Daniela C. Gey, Jennifer F. Hoy, Eric A. Krum, Ray Nelson, Daniel E. Nixon, Nick Paton, Court Pedersen, George Perez, Richard W. Price, Ronald J. Prineas, Frank S. Rhame, James Sampson, John Worley & INSIGHT Cause of Death Writing Group
Pages: 177-185
Published online: 06 Jan 2015
AbstractforDetermination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials | References | PDF (143.8 KB)
  • 134 Views
  • 34 CrossRef citations
  • 0Altmetric
Free Access
Article
Virologic Success in an Urban HIV Clinic: Outcome at 12 Months in Patients Who Were HAART Naïve
Edward Blanchard, Olga M. Klibanov, Peter Axelrod, Brandon Palermo & Rafik Samuel
Pages: 186-191
Published online: 06 Jan 2015
AbstractforVirologic Success in an Urban HIV Clinic: Outcome at 12 Months in Patients Who Were HAART Naïve | References | PDF (117 KB)
  • 56 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
ABCB1 Allele Polymorphism Is Associated with Virological Efficacy in Naïve HIV-Infected Patients on HAART Containing Nonboosted PIs But Not Boosted PIs
X. de la Tribonnière, F. Broly, S. Deuffic-Burban, L. Bocket, F. Ajana, N. Viget, H. Melliez, Y. Mouton & Y. Yazdanpanah
Pages: 192-201
Published online: 06 Jan 2015
AbstractforABCB1 Allele Polymorphism Is Associated with Virological Efficacy in Naïve HIV-Infected Patients on HAART Containing Nonboosted PIs But Not Boosted PIs | References | PDF (186.6 KB)
  • 31 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Brief reports

Brief Report
How Long Is the Window of Opportunity Between Adherence Failure and Virologic Failure on Efavirenz-Based HAART?
Robert Gross, Warren B. Bilker, Hao Wang & Jennifer Chapman
Pages: 202-206
Published online: 06 Jan 2015
AbstractforHow Long Is the Window of Opportunity Between Adherence Failure and Virologic Failure on Efavirenz-Based HAART? | References | PDF (118.5 KB)
  • 34 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Brief Report
Higher Plasma Myeloperoxidase Levels Are Not Associated with an Increased Risk for Cardiovascular Events in HIV-Infected Adults
Dalia El-Bejjani, Stanley L. Hazen, Wilma Mackay, Nina E. Glass, Todd Hulgan, Marisa Tungsiripat & Grace A. McComsey
Pages: 207-211
Published online: 06 Jan 2015
AbstractforHigher Plasma Myeloperoxidase Levels Are Not Associated with an Increased Risk for Cardiovascular Events in HIV-Infected Adults | References | PDF (104.4 KB)
  • 50 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Parenting with HIV: a patient’s view on updated infant feeding guidelines in the US
Ciarra Covin
Comment | Published online: 4 Jun 2024
Open Access
Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV
Arianna E. Kousari et al.
Article | Published online: 3 Jun 2024
Open Access
Understanding the lived experience research priorities for improving health-related quality of life in people living with HIV with cognitive impairment
Kate Alford et al.
Article | Published online: 3 Jun 2024
Open Access
Clinical characteristics and outcomes of people living with HIV and ocular syphilis during the COVID-19 health emergency
Edgar Pérez-Barragán et al.
Brief Report | Published online: 3 Jun 2024
Open Access